米索前列醇辅助治疗剖宫产重度产后出血的临床观察  

Clinical observation of misoprostol in the treatment of severe postpartum hemorrhage in cesarean section

作　　者：徐怀艳 刘振华 

机构地区：[1]临沂市罗庄区人民医院,山东临沂276017

出　　处：《现代医学与健康研究电子杂志》2017年第9期24-25,共2页Modern Medicine and Health Research

摘　　要：目的探讨米索前列醇对于提高剖宫产重度产后出血临床治疗效果的影响。方法选取我院妇产科2015年5月~2016年8月期间收治的94例剖宫产重度产后出血患者作为研究对象,将其随机分为观察组(缩宫素+米索前列醇)和对照组(缩宫素)47例,观察两组患者的产后出血情况。结果与对照组相比,观察组患者的术后24h出血量[(194.65±58.85)ml<(291.14±60.82)ml]相对更低(P<0.05)。结论米索前列醇的应用,对于提高剖宫产重度产后出血临床治疗效果有着积极的影响。Objective To investigate the effect of misoprostol for improving cesarean section clinical therapeutic effect of severe postpartum hemorrhage. Methods selected in our hospital of Obstetrics and gynecology in May 2015 ~ 2016 year in August 94 cases of cesarean section in patients with severe postpartum hemorrhage as the research object,which were randomly divided into observation group( oxytocin + misoprostol) and control( oxytocin group) 47 cases,two groups were observed in patients with postpartum hemorrhage. Results compared with control group,the amount of bleeding in the observation group [24 h patients( 194. 65 + 58. 85) ml <( 291. 14 + 60. 82) ml]is relatively lower( P<0. 05). Conclusion misoprostol application for improving cesarean section of severe postpartum hemorrhage clinical treatment effect has a positive impact.

关 键 词：米索前列醇 剖宫产 产后出血 

分 类 号：R714.461[医药卫生—妇产科学]